Effect of a Peripheral NMDA Receptor Antagonist on Glutamate-Evoked Masseter Muscle Pain and Mechanical Sensitization in Women

Aims: To test the hypothesis that local injection of the N-methyl-D-aspartate (NMDA) receptor antagonist ketamine would significantly attenuate glutamate-evoked masseter mechanical sensitization and muscle pain in healthy young women either taking oral contraceptives (W+OC) or not taking oral contraceptives (W-OC). Methods: Experimental pain was evoked in 47 healthy female subjects (W+OC, n = 25; W-OC, n = 22) by 2 injections of glutamate (0.2 mL, 1 mol/L) into the masseter muscle. A first injection of glutamate alone was followed by a second injection, 35 minutes later, of glutamate combined with ketamine (0, 1, or 10 mmol/L). Evoked pain intensity was scored on a 10-cm electronic visual analog scale (VAS). Distribution of perceived pain was drawn on a lateral view of the face (pain drawing). Masseter muscle pressure pain thresholds (PPT) and pressure-pain tolerances (PPTOL) were determined bilaterally before and at regular time intervals after injections. Analyses of variance (ANOVA) were used to test the data. Results: There were no main effects of ketamine on any of the VAS pain parameters or on the pain drawing (ANOVAs: P > .055). Furthermore, there were no differences in PPT, PPTOL, VAS peak pain, duration, overall VAS pain, or pain drawing when W-OC were compared with W+OC (ANOVAs: P > .087). Repeated injection of glutamate alone significantly decreased PPT and PPTOL (ANOVAs: P < .001); however, this effect was not significantly attenuated by ketamine. Conclusions: Peripherally administered ketamine had no effect on glutamate-evoked masseter muscle pain and sensitization in healthy young women, which contrasts with recent observations in healthy young men. Further studies will be needed to reveal the mechanisms that underlie this apparent sex-related difference in ketamine-mediated analgesia.

glutamate; ketamine; muscle pain; orofacial pain; temporomandibular disorders; trigeminal physiology

1. Lam DK, Sessle BJ, Cairns BE, Hu JW. Neural mechanisms of temporomandibular joint and masticatory muscle pain: A possible role for peripheral glutamate receptor mechanisms. Pain Res Manag 2005;10:145–152.

2. Carlsson GE, LeResche L. Epidemiology of temporomandibular disorders. In: Sessle BJ, Bryan PS, Dionne RA (eds). Epidemiology of Temporomandibular Disorders. Seattle, WA: IASP Press, 1995.

3. Stohler CS. Muscle-related temporomandibular disorders. J Orofac Pain 1999;13:273–284.

4. Ernberg M, Hedenberg-Magnusson B, Alstergren P, Lundeberg T, Kopp S. Pain, allodynia, and serum serotonin level in orofacial pain of muscular origin. J Orofac Pain 1999;13:56–62.

5. Alfredson H, Forsgren S, Thorsen K, Lorentzon R. In vivo microdialysis and immunohistochemical analyses of tendon tissuedemonstrated high amounts of free glutamate and glutamate NMDAR1 receptors, but no signs of inflammation, in Jumper’s knee. J Orthop Res 2001;19: 881–886.

6. Alfredson H, Lorentzon R. Chronic tendon pain: No signs of chemical inflammation but high concentrations of the neurotransmitter glutamate. Implications for treatment?Curr Drug Targets 2002;3:43–54.

7. McNearney T, Speegle D, Lawand N, Lisse J, Westlund KN. Excitatory amino acid profiles of synovial fluid from patients with arthritis. J Rheumatol 2000;27:739–745.

8. Cairns BE, Wang K, Hu JW, Sessle BJ, Arendt-Nielsen L, Svensson P. The effect of glutamate-evoked masseter muscle pain on the human jaw-stretch reflex differs in men and women. J Orofac Pain 2003;17:317–325.

9. Cairns BE, Svensson P, Wang K, et al. Activation of peripheral NMDA receptors contributes to human pain and rat afferent discharges evoked by injection of glutamate into the masseter muscle. J Neurophysiol 2003;90: 2098–2105.

10. Cairns BE, Hu JW, Arendt-Nielsen L, Sessle BJ, Svensson

P. Sex-related differences in human pain and rat afferent discharge evoked by injection of glutamate into the masseter muscle. J Neurophysiol 2001;86:782–791.

11. Svensson P, Cairns BE, Wang K, et al. Glutamate-evoked pain and mechanical allodynia in the human masseter muscle. Pain 2003;101:221–227.

12. Wang K, Sessle BJ, Svensson P, Arendt-Nielsen L. Glutamate evoked neck and jaw muscle pain facilitate the human jaw stretch reflex. Clin Neurophysiol 2004;115:1288–1295.

13. Cairns BE, Gambarota G, Dunning PS, Mulkern RV, Berde CB. Activation of peripheral excitatory amino acid receptors decreases the duration of local anesthesia. Anesthesiology 2003;98:521–529.

14. Cairns BE, Svensson P, Wang K, et al. Ketamine attenuates glutamate-induced mechanical sensitization of the masseter muscle in human males. Exp Brain Res 2006; 169:467–472.

15. Carlton SM. Peripheral excitatory amino acids. Curr Opin Pharmacol 2001;1:52–56.

16. Isselee H, De Laat A, De Mot B, Lysens R. Pressure-pain threshold variation in temporomandibular disorder myalgia over the course of the menstrual cycle. J Orofac Pain 2002;16:105–117.

17. Isselee H, De Laat A, Bogaerts K, Lysens R. Long-term fluctuations of pressure pain thresholds in healthy men, normally menstruating women and oral contraceptive users. Eur J Pain 2001;5:27–37.

18. Drobek W, Schoenaers J, De Laat A. Hormone-dependent fluctuations of pressure pain threshold and tactile threshold of the temporalis and masseter muscle. J Oral Rehabil 2002;29:1042–1051.

19. LeResche L, Sherman JJ, Huggins K, et al. Musculoskeletal orofacial pain and other signs and symptoms of temporomandibular disorders during pregnancy: A prospective study. J Orofac Pain 2005;19:193–201.

20. Zubieta JK, Smith YR, Bueller JA, et al. Mu-opioid receptor-mediated antinociceptive responses differ in men and women. J Neurosci 2002;22:5100–5107.

21. Dworkin SF, LeResche L. Research Diagnostic Criteria for Temporomandibular Disorders: Review, criteria, examinations and specifications, critique. J Craniomandib Disord 1992;6:301–355.

22. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315–324.

23. Svensson P, Graven-Nielsen T, Arendt-Nielsen L. Mechanical hyperesthesia of human facial skin induced by tonic painful stimulation of jaw muscles. Pain 1998;74: 93–100.

24. Svensson P, Arendt-Nielsen L, Nielsen H, Larsen JK. Effect of chronic and experimental jaw muscle pain on pain-pressure thresholds and stimulus-response curves. J Orofac Pain 1995;9:347–356.

25. Cairns BE, Gambarota G, Svensson P, Arendt-Nielsen L, Berde CB. Glutamate-induced sensitization of rat masseter muscle fibers. Neuroscience 2002;109:389–399.

26. Cairns BE, Sessle BJ, Hu JW. Evidence that excitatory amino acid receptors within the temporomandibular joint region are involved in the reflex activation of the jaw mus-cles. J Neurosci 1998;18:8056–8064.

27. Walker JS, Carmody JJ. Experimental pain in healthy human subjects: Gender differences in nociception and in response to ibuprofen. Anesth Analg 1998;86:1257–1262.

28. Gear RW, Gordon NC, Heller PH, Paul S, Miaskowski C, Levine JD. Gender difference in analgesic response to the kappa-opioid pentazocine. Neurosci Lett 1996;205: 207–209.

29. Wiesenfeld-Hallin Z. Sex differences in pain perception. Gend Med 2005;2:137–145.

30. Fillingim RB, Ness TJ, Glover TL, Campbell CM, Price DD, Staud R. Experimental pain models reveal no sex differences in pentazocine analgesia in humans. Anesthesiology 2004;100:1263–1270.

31. Fillingim RB, Ness TJ, Glover TL, et al. Morphine responses and experimental pain: Sex differences in side effects and cardiovascular responses but not analgesia. J Pain 2005;6:116–124.

32. Fillingim RB, Hastie BA, Ness TJ, Glover TL, Campbell CM, Staud R. Sex-related psychological predictors of baseline pain perception and analgesic responses to pentazocine. Biol Psychol 2005;69:97–112.

33. Fillingim RB, Gear RW. Sex differences in opioid analgesia: Clinical and experimental findings. Eur J Pain 2004; 8:413-425.

34. Christidis N, Kopp S, Ernberg M. The effect on mechanical pain threshold over human muscles by oral administration of granisetron and diclofenac-sodium. Pain 2005; 113:265–270.

35. Ernberg M, Lundeberg T, Kopp S. Effect of propranolol and granisetron on experimentally induced pain and allodynia/hyperalgesia by intramuscular injection of serotonin into the human masseter muscle. Pain 2000;84:339–346.

36. De Laat A, Stappaerts K, Papy S. Counseling and physical therapy as treatment for myofascial pain of the masticatory system. J Orofac Pain 2003;17:42–49.

37. Isselee H, De Laat A, Bogaerts K, Lysens R. Short-term reproducibility of pressure pain thresholds in masticatory muscles measured with a new algometer. J Orofac Pain 1998;12:203–209.

38. Dao TT, LeResche L. Gender differences in pain. J Orofac Pain 2000;14:169–184.

39. Chesterton LS, Barlas P, Foster NE, Baxter GD, Wright

CC. Gender differences in pressure pain threshold in healthy humans. Pain 2003;101:259–266.

40. Ernberg M, Hedenberg-Magnusson B, Alstergren P, Kopp

S. The level of serotonin in the superficial masseter muscle in relation to local pain and allodynia. Life Sci 1999; 65:313–325.